Trust Board papers November 2012 - Barking Havering and ...

5. CAPITAL AND CASHFLOW
Summary Cashflow - Year to date
£000's
Operating Deficit (9,601)
Interest Paid (12,266)
PDC Dividend Paid 0
Interest received 204
Impairments (1,728)
Transfers -
Net I&E deficit (cash impact) (23,390)
Depreciation and Amortisation 5,933
Movements in w orking balances:
Decrease in Inventories (5)
Increase in Trade and Other Receivables 2,126
Increase in Trade and Other Payables 23,159
Decrease in Provisions (1,622)
- sub-total 6,201
Capital expenditure (6,646)
Revenue Rental Income 546
Net cashflow before financing 101
Capital Element of Finance Leases and PFI (3,002)
Loans repaid -
Public Dividend Capital Received -
Net Increase/(Decrease) in Cash and
Cash Equivalents
(2,901)
Opening cash balance 4,343
Closing cash balance 1,442
Capital Programme Summary Aug-12
Total
Approved
Total
Proposed
Total
Funding
YTD
Expenditure
2012-13 2012-13 2012-13
Internally Funded Assets
Medical Equipment 1,926 1,848 3,774 1,609
IT - Hardware 1,429 299 1,728 737
IT - Software 482 0 482 88
Other Plant & Machinery 500 0 500 0
Estates 3,372 382 3,754 962
sub-Total 7,709 2,529 10,238 3,395
Externally Funded Assets
Pathology 4,342 900 5,242 525
SAN 967 0 967 711
MLU 2,396 0 2,396 217
Access Funded Assets 117 0 117 49
sub-Total 7,822 900 8,722 1,503
Trust Variation Enquiries 3,380 0 3,380 225
Total Trust - Funded 18,911 3,429 22,340 5,123
Subject to External Approval & Funding
Cardiac Cath Lab 0 1,700 1,700 0
CT Scanners 0 2,000 2,000 0
A&E Reconfiguration 0 3,000 3,000 0
Digital Mammography 0 1,548 1,548 0
PAS Replacement 0 10,000 10,000 0
sub-Total 0 18,248 18,248 0
Total Capital Plan to Date 18,911 21,677 40,588 5,123
Total Trust Submitted Plan 40,011
Balance to Submitted Plan (577)
Assets to be Considered via Charitable Funds
Da Vinci Robot 0 2,400 2,400
Cashflow - Key points:
• The net cash position decreased from £5.4 to £1.4
in August.
Capital - Key points:
• Against the total Trust Capital Plan of £40.9m, £18.3m of externally
funded schemes have yet to be fully approved (including PAS). Of
the remaining £22.6m, £19.2m of projects have been approved, with
a further £3.4m awaiting business case approval.
• Against this position, year to date capital expenditure is £5.1m, an increase
of £1.3m compared with July.
• The Trust has frozen all non-essential capital schemes, pending mitigation
of risk in achieving the £40m revenue control total
14